Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 5, 1996

View Archived Issues

RPR continues research into taxanes

Antitumor enhancers claimed by Taiho

Japanese researchers disclose substance P antagonists

Phase IIa trial on Isis antiinflammatory antisense compound completed

Patent issued for Vical's core technology

New company formed with focus on women's health

E-Z-EM introduces new dysphagia diagnostic kit

Incyte and Abbott expand genomic database agreement

Priority review for Crinone

Sterinetics System successfully inactivates multiple viruses in IVIg

RTP to accelerate development of insoluble drug delivery technology

Houghten's lead CRA safe in diabetics

New patient-activated drug delivery system from Medtronic released in Europe

Moisture-managing foam wound dressing introduced

GenPharm generates human anti-IL-8 antibodies

Phase II trials begin on low-dose interferon alfa for Sjogren's syndrome

Shareholder meeting set to approve Bio-Dental-Zila merger

Cytel announces plans for Cylexin at investors conference

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026